Central Drug Research Institute / National Institute of Child Health / ER complex / Shanghai Institute / University of Tennessee Health Science Center / University of California / /
IndustryTerm
breast cancer therapies / bicyclononene ring systems / endocrine regulatory systems / nongynecological applications / breast cancer therapy / hydrogen-bridge network / breast cancer treatment / hydrogen-bond network / microarray technology / computer algorithm / therapeutic applications / /
MedicalCondition
node-positive breast cancer / IBD / stress-related diseases / human hypertension / carcinogen-induced rat mammary cancer / long-term breast cancer / human endometrial carcinoma / Alzheimers disease / ER-negative invasive breast cancer / experimental autoimmune encephalomyelitis / prostate cancers / rheumatoid arthritis / antiandrogen withdrawal syndrome / carcinogen-induced rat mammary tumors / hyperaldosteronism / estrogen-responsive breast cancers / dependent allergic asthma / chronic kidney disease / pulmonary eosinophilic inflammation / hypogonadism / renal disease / ER-positive invasive breast cancer / coronary heart disease / aldosteronism / bowel disease / metabolic disorders / prostate cancer / MS / Index Conns syndrome / cardiovascular diseases / breast cancer / antihormonal-resistant breast cancer / autoimmune diseases / mouse mamma tumor virus / Addison disease / node-positive disease / cancer / atherosclerosis / chronic heart failure / androgen-insensitivity syndrome / salt-sensitive hypertension / chronic obstructive pulmonary disease / dyslipidemia / node-negative breast cancer / tamoxifen-stimulated tumor / endometriosis / postmenopausal osteoporosis / dysfunctional uterine bleeding / metabolic syndrome / tumor necrosis / breast tumors / postmenopausal vaginal syndrome / aldosterone-producing adrenal tumor / post-myocardial infarction / osteoporosis / high blood pressure / prostate tumors / autoimmune prostatitis / autoimmune thyroiditis / syndrome / /
MedicalTreatment
oral contraceptives / breast cancer therapy / HRT / hormone replacement therapy / testosterone replacement / dendrimer / breast cancer therapies / in vitro fertilization / adjuvant therapy / /
Organization
Food and Drug Administration / Reserve Bank of Australia / University of Tennessee / Shanghai Institute for Biological Sciences / American Cancer Society / Tennessee Health Science Center / Central Drug Research Institute / University of California in San Francisco / National Institute of Child Health and Human Development / /
j489 Index 4-OH- tamoxifen 38, 140, 147 – breast cancer patients 140 – estrogen-like actions 147